The aim of this study was to define the association between CESM findings and prognostic factors, such as ER, PR, HER2, and Ki67, with the aim to offer an updated overview of state of the art for the early differential diagnosis of breast cancer and the following personalized treatments. The gene discussed is ERBB2; the disease is breast cancer.